News
Stock Screener
Small Caps
Guru Portfolios
Review
More
EN
РУ
EN
News
Stock Screener
Small Caps
Guru Portfolios
Review
#
Pharmaceutical Companies
: 104
News
·
06.08.2025 00:15
UBS no longer advises buying shares in the maker of Ozempic. Is it inferior to a competitor?
LLY
NOVO-B.CO
News
·
01.08.2025 03:07
Pharma stocks plummet after Trump's demand for price cuts. Should we be worried?
LLY
NVO
PFE
Small Caps
·
30.07.2025 11:46
Shares in biotech Sarepta soar after FDA allows shipments of Elevidys to resume
SRPT
News
·
29.07.2025 21:37
Novo Nordisk shares are having their worst day in almost 40 years. The company downgraded its outlook again
NOVO-B.CO
LLY
Small Caps
·
22.07.2025 13:20
After third patient death this year, HC Wainwright cuts TP on Sarepta to zero
SRPT
Review
·
19.07.2025 15:02
Business in the age of Ozempic: who will benefit from the growing popularity of weight loss drugs
NVO
LLY
NESN.SW
News
·
16.07.2025 18:38
Pandemic pets taken from shelters are aging out. Which company will capitalize on this?
CHWY
Small Caps
·
09.07.2025 17:30
Biotech ProKidney soars 500% after positive trial results, but analysts are cautious
PROK
Small Caps
·
01.07.2025 17:47
Freedom Broker says buy Hims & Hers after cancellation of tie-up with Novo Nordisk
HIMS
News
·
30.06.2025 17:50
China approves Ozempic's first domestic competitor. What do investors need to know?
NOVO-B.CO
LLY
News
·
24.06.2025 04:17
Eli Lilly is entering a market valued at $30 billion, can it beat the competition?
LLY
NVO
AZN
News
·
17.06.2025 21:00
Novo Nordisk shares recovered after the collapse. What will happen to the company next?
NVO
Load more